Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.

C Unger; B Häring; A Kruse; A Thumann; B Schneider; C Clemm; B Weber; H D Clevert; S Hockertz; M B Kalousek

doi:10.1055/s-0031-1300046

Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.

Identifier:nobleid.org/w1/20260515/ABC14CE8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ABC14CE8.svg?ark=w1%2F20260515%2FABC14CE8)](https://nobleid.org/work/w1/20260515/ABC14CE8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer.

Identifier:nobleid.org/w1/20260515/ABC14CE8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ABC14CE8.svg?ark=w1%2F20260515%2FABC14CE8)](https://nobleid.org/work/w1/20260515/ABC14CE8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work